Ramadurai S M, Nielsen H C, Chen Y, Hatzis D, Sosenko I R
Department of Pediatrics, Floating Hospital for Children, New England Medical Center, Boston, Massachusetts 02111, USA.
Exp Lung Res. 1998 Sep-Oct;24(5):641-57. doi: 10.3109/01902149809099585.
Antenatal administration of triiodo-L-thyronine (T3) to late gestation rats resulted in decreased lung antioxidant enzyme (AOE) activity but increased surfactant phospholipids. In fetal rat lung explant cultures, T3 decreased the expression of surfactant proteins (SP) A and B. There have been no reported studies of the simultaneous in vivo developmental influence of T3 on both pulmonary AOE and SP gene expression. We hypothesized that antenatal T3 treatment would cause differential regulation of surfactant phospholipid, SP, and AOE genes in the late gestation fetal rat. Timed pregnant rats received intramuscular injections of either T3 (7 mg/kg) or placebo on days 19 and 20 of gestation and fetuses were delivered on day 21. Fetal lung SP-A, SP-B, SP-C, and AOE mRNA levels were studied by Northern analysis. AOE mRNA levels were further quantitated by solution hybridization. Total lung phospholipids (TPL) and disaturated phosphatidylcholine (DSPC) content were quantitated by a phosphorus assay. T3 significantly increased TPL and DSPC content, and significantly decreased the expression of SP-A, SP-C, CuZnSOD, and catalase genes. Because of a crucial interplay of these factors for normal lung function at the time of birth, the molecular mechanisms by which these apparently opposing changes are accomplished warrant further investigation.
在妊娠晚期大鼠中进行产前三碘-L-甲状腺原氨酸(T3)给药,结果显示肺抗氧化酶(AOE)活性降低,但表面活性物质磷脂增加。在胎鼠肺外植体培养中,T3降低了表面活性物质蛋白(SP)A和B的表达。目前尚无关于T3对肺AOE和SP基因表达同时产生体内发育影响的报道研究。我们假设产前T3治疗会导致妊娠晚期胎鼠中表面活性物质磷脂、SP和AOE基因的差异调节。在妊娠第19天和第20天,对定时受孕的大鼠进行肌肉注射T3(7mg/kg)或安慰剂,在第21天分娩胎儿。通过Northern分析研究胎肺SP-A、SP-B、SP-C和AOE mRNA水平。通过溶液杂交进一步定量AOE mRNA水平。通过磷测定法定量总肺磷脂(TPL)和二饱和磷脂酰胆碱(DSPC)含量。T3显著增加TPL和DSPC含量,并显著降低SP-A、SP-C、铜锌超氧化物歧化酶(CuZnSOD)和过氧化氢酶基因的表达。由于这些因素在出生时对正常肺功能起着关键的相互作用,实现这些明显相反变化的分子机制值得进一步研究。